CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK/p300 axis
CPVL (carboxypeptidase, vitellogenic-like) is a serine carboxypeptidase that was first characterized in human macrophages. However, the function of CPVL remains unclear in a variety of tumors. The quantitative PCR (qPCR), Western blotting, and IHC assays were utilized to measure the CPVL expression....
Main Authors: | Hui Yang, Xiaocen Liu, Xiaolong Zhu, Xueqin Li, Lan Jiang, Min Zhong, Mengying Zhang, Tianbing Chen, Mingzhe Ma, Xiuming Liang, Kun Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-12-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.146362 |
Similar Items
-
A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models
by: Zheng Zhong, et al.
Published: (2022-06-01) -
GINS1 promotes the proliferation and migration of glioma cells through USP15-mediated deubiquitination of TOP2A
by: Hui Yang, et al.
Published: (2022-09-01) -
Prospects for using ultrasound of various intensity for the treatment of patients with malignant brain gliomas
by: O. S. Regentova, et al.
Published: (2024-03-01) -
Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancer
by: Xinan Wang, et al.
Published: (2024-12-01) -
Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis
by: Wanyi Sun, et al.
Published: (2023-06-01)